Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module

Deborah B Diercks1, Gregg C Fonarow, J Douglas Kirk

  • 1University of California, Davis Medical Center, Sacramento, CA, USA. dbdiercks@ucdavis.edu

Insights

The Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM) Classification and Regression Tree (CART) model effectively predicts heart failure risk in both men and women. This tool ensures accurate risk stratification regardless of gender, improving patient care.

Area of Science:

  • Cardiology
  • Clinical Research
  • Health Outcomes

Background:

  • Heart failure mortality risk may differ between genders, potentially due to comorbid conditions.
  • Existing risk stratification algorithms may have limited performance in women with heart failure.
  • Understanding gender-specific risk profiles is crucial for effective heart failure management.

Purpose of the Study:

  • To evaluate the performance of a published risk stratification model in predicting outcomes for women with heart failure.
  • To determine if the ADHERE Registry CART model effectively stratifies risk in female heart failure patients.

Main Methods:

  • Utilized the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM) database.
  • Compared characteristics, treatments, and outcomes between male and female patients.
  • Applied the ADHERE Registry Classification and Regression Tree (CART) analysis for risk stratification.

Main Results:

  • In-hospital mortality was similar between men and women (52.2% of 10,984 patients were women).
  • Significant gender differences were observed in CART model variables: elevated blood urea nitrogen (BUN), low systolic blood pressure, and high serum creatinine.
  • The CART model successfully stratified both genders into distinct risk groups with no significant gender-based mortality differences within these groups.

Conclusions:

  • The ADHERE Registry CART tool demonstrates effectiveness in predicting risk for emergency department patients with heart failure.
  • The model's predictive capability is consistent across genders, making it a valuable tool for all patients.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...